Slit2 treatment further induced gene expression associated with a tumor-promoting macrophage phenotype by activating MMP-9, VEGF-a, Mrc1, Ccl19, TGF-β1, IL-10, Cd209a, and Arg1. This evidence concerns the gene TGFB1 and neoplasm.